Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIANP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC100133669 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HAAO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC171 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FTCDNL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEFB107B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBPMS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1RL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAZ2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FN3K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PKD2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C14orf105 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on